ANI Pharma Inc (NQ: ANIP )

28.95 USD +1.23 (+4.44%)

Official Closing Price Updated: 4:03 PM EDT, Oct 23, 2020 Add to My Watchlist

Price and Volume

Volume	49,800
Open	27.68
Bid (Size)	28.92 (2)
Ask (Size)	28.97 (6)
Prev. Close	27.72
Today's Range	27.68 - 29.21
52wk Range	25.23 - 80.87
Shares Outstanding	11,786,416
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

ANI Pharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

September 10, 2020

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that the Compensation Committee of ANI’s Board of Directors granted a non-qualified inducement stock option to purchase...

ANI Pharmaceuticals Reports Second Quarter 2020 Results

August 06, 2020

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced business highlights and financial results for the three and six months ended June 30, 2020.

Performance

YTD	-51.81%	-51.81%
1 Month	+2.92%	+2.92%
3 Month	+9.20%	+9.20%
6 Month	-30.69%	-30.69%
1 Year	-62.71%	-62.71%

More News

ANI Pharmaceuticals Appoints Experienced Pharmaceutical Executives, Jeanne Thoma and Antonio “Tony” Pera to Board of Directors

August 06, 2020

ANI Pharmaceuticals Announces Acquisition of Fluconazole Tablets

July 06, 2020

ANI Pharmaceuticals Names Nikhil Lalwani as President and Chief Executive Officer

August 03, 2020

ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules

June 30, 2020

ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter 2020 Financial Results

July 30, 2020

ANI Pharmaceuticals Provides Update on Recent Regulatory Filing

June 01, 2020

ANI Pharmaceuticals Reports First Quarter 2020 Results and Appoints Interim CEO

May 07, 2020

Add Up The Parts: SPSM Could Be Worth $32

August 27, 2020

Look Under The Hood: EES Has 14% Upside

July 27, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.